SCLEROATROPHIC LICHEN - CURRENT DATA ON THE ETIOLOGY, PATHOGENESIS, CLINICAL FEATURES AND TREATMENT

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract


Scleroatrophic lichen (SL) - chronic autoimmune dermatosis, is one of the clinical variants of limited scleroderma, characterized by multifactorial genesis of development against the background of immunological changes, vascular and metabolic disorders in the connective tissue, which is characterized by severe focal atrophy of the skin and mucous membranes of the external genitals. SL is a debilitating disease causing itching, pain, dysuria and impaired urination, dyspareunia and significant sexual dysfunction in women and men. This article presents a review of current literature data on the etiology and pathogenesis, clinical picture, classification, differential diagnosis of the disease, as well as methods of treatment of patients. This review is based on the analysis of 64 articles, which were obtained from eLibrary, PubMed, NCBI, Embase.

Full Text

Restricted Access

About the authors

Yulia Aleksandrovna Semenchak

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Email: julia19921992@bk.ru
Moscow, 119991, Russian Federation
Department of Dermatology and Venereology

References

  1. Гусева Н.Г. Системная склеродермия - мультидисциплинарная проблема. Научно-практическая ревматология. 2011; 2: 10-4.
  2. Higgins C.A., Cruickshank M.E. A population-based case-control study of aetiological factors associated with vulval lichen sclerosus. J. Obstet. Gynaecol. 2012; 32(3): 271-5.
  3. McPherson T., Cooper S. Vulval lichen sclerosus and lichen planus. Dermatol. Ther. 2010; 23(5): 523-32.
  4. Edmonds E.V., Hunt S., Hawkins D., Dinneen M., Francis N., Bunker C.B. Clinical parameters in male genital lichen sclerosus: a case series of 329 patients. J. Eur. Acad. Dermatol. Venereol. 2012; 26(6): 730-7.
  5. Молочков В.А., Снарская Е.С., Ромашкина А.С. Очаговая склеродермия, ассоциированная с другими аутотиммунными заболеваниями и спектром различных аутоантител. Российский журнал кожных и венерических болезней. 2011; 4: 33-36.
  6. Goldstein A.T., Marinoff S.C., Christopher K., Srodon M. Prevalence of vulvar lichen sclerosus in a general gynecology practice. J. Reprod. Med. 2005; 50(7): 477-80.
  7. Kreuter A., Kryvosheyeva Y., Terras S., Moritz R., Mollenhoff K., Altmeyer P., et al. Association of autoimmune diseases with lichen sclerosus in 532 male and female patients. Acta Derm. Venereol. 2013; 93(2): 238-41.
  8. Powell J., Wojnarowska F. Childhood vulvar lichen sclerosus: an increasingly common problem. J. Am. Acad. Dermatol. 2001; 44(5): 803-6.
  9. Kizer W.S., Prarie T., Morey A.F. Balanitis xerotica obliterans: epidemiologic distribution in an equal access health care system. South Med. J. 2003; 96(1): 9-11.
  10. Nelson D.M., Peterson A.C. Lichen sclerosus: epidemiological distribution in an equal access health care system. J. Urol. 2011; 185(2): 522-5.
  11. Bleeker M.C., Visser P.J., Overbeek L.I., van Beurden M., Berkhof J. Lichen sclerosus: incidence and risk of vulvar squamous cell carcinoma. Cancer Epidemiol. Biomarkers Prev. 2016; 25(8): 1224-30.
  12. Kirtschig G., Kuik D.J. A dutch cohort study confirms familial occurrence of anogenital lichen sclerosus. J. Women’s Health Care. 2014; 3(6): 209-11.
  13. Соколова А.А, Гребенюк В.Н., Доля О.В. Клинические особенности генитального склероатрофичкеского лихена у мужчин и женщин. Клиническая дерматология и венерология. 2016; 1: 54-9.
  14. Smith S.D., Fischer G. Childhood onset vulvar lichen sclerosus does not resolve at puberty: a prospective case series. Pediatr. Dermatol. 2009; 26(6): 725-9.
  15. Соколова А.А., Гребенюк В.Н., Доля О.В. Клиническая характеристика склероатрофического лихена у детей. Клиническая дерматология и венерология. 2015; 1: 75-8.
  16. Padmavathy L., Lakshmana Rao L., Dhana Laksnmi M., Sylvester N., Ethirajan N. Lichen sclerosus atrophicus (LSA) in the Areolae: a case report. Case Rep. Dermatol. Med. 2012; 2012: 825963.
  17. Sahn E.E., Bluestein E.L., Oliva S. Familial lichen sclerosus et atrophicus in childhood. Pediatr. Dermatol. 1994; 11(2): 160-3.
  18. Sherman V., McPherson T., Baldo M., Salim A., Gao X.H., Wojnarowska F. The high rate of familial lichen sclerosus suggests a genetic contribution: an observational cohort study. J. Eur. Acad. Dermatol. Venereol. 2010; 24(9): 1031-4.
  19. Kreuter A., Kryvosheyeva Y., Terras S., Moritz R., Mollenhoff K., Altmeyer P., et al. Association of autoimmune diseases with lichen sclerosus in 532 male and female patients. Acta Derm. Venereol. 2013; 93(2): 238-41.
  20. Murphy R. Lichen sclerosus. Dermatol. Clin. 2010; 28(4): 707-15.
  21. Birenbaum D.L., Young R.C. High prevalence of thyroid disease in patients with lichen sclerosus. J. Reprod. Med. 2007; 52(1): 28-30.
  22. Leese G.P., Flynn R.V., Jung R.T., Macdonald T.M., Murphy M.J., Morris A.D. Increasing prevalence and incidence of thyroid disease in Tayside, Scotland: the Thyroid Epidemiology Audit and Research Study (TEARS). Clin. Endocrinol. (Oxf). 2008; 68(2): 311-6.
  23. Gao X.H., Barnardo M.C., Winsey S., Ahmad T., Cook J., Agudelo J.D., et al. The association between HLA DR, DQ antigens, and vulval lichen sclerosus in the UK: HLA DRB112 and its associated DRB112/DQB10301/04/09/010 haplotype confers susceptibility to vulval lichen sclerosus, and HLA DRB10301/04 and its associated DRB10301/04/DQB10201/02/03 haplotype protects from vulval lichen sclerosus. J. Invest. Dermatol. 2005; 125(5): 895-9.
  24. Howard A., Dean D., Cooper S., Kirtschig G., Wojnarowska F. Circulating basement membrane zone antibodies are found in lichen sclerosus of the vulva. Ausralas J. Dermatol. 2004; 45(1): 12-5.
  25. Baldo M., Bailey A., Bhogal B., Groves R.W., Ogg G., Wojnarowska F. T cells reactive with the NC16A domain of BP180 are present in vulval lichen sclerosus and lichen planus. J. Eur. Acad. Dermatol. Venereol. 2010; 24(2): 186-90.
  26. Gambichler T., Hoxtermann S., Skrygan M., Eberz B., Regauer S., Scola N., Kreuter A. Occurrence of circulating anti-bullous pemphigoid antibodies in patients with lichen sclerosus. J. Eur. Acad. Dermatol. Venereol. 2011; 25(3): 369-70.
  27. Gambichler T., Terras S., Kreuter A., Skrygan M. Altered global methylation and hydroxymethylation status in vulvar lichen sclerosus - further support for epigenetic mechanisms. Br. J. Dermatol. 2014; 170(3): 687-93.
  28. Patsatsi A., Kyriakou A., Mantas A., Vavilis D., Patsialas C., Sotiriadis D. Circulating anti-BP180 NC16a and anti-BP230 autoantibodies in patients with genital lichen sclerosus do not correlate with the disease activity and pruritus. Acta Dermatol. Venereol. 2014; 94(6): 711-2.
  29. Abdelbaky A.M., Aluru P., Keegan P., Greene D.R. Development of male genital lichen sclerosus in penile reconstruction skin grafts after cancer surgery: an unreported complication. B.J.U. Int. 2012; 109(5): 776-9.
  30. Neill S.M., Lewis F.M., Tatnall F.M., Cox N.H.; British Association of Dermatologists. British Association of Dermatologists guidelines for the management of lichen sclerosus, 2010. Br. J. Dermatol. 2010; 163(4): 672-82.
  31. Rimoin L.P., Kwatra S.G., Yosipovitch G. Female-specific pruritus from childhood to postmenopause: clinical features, hormonal factors, and treatment considerations. Dermatol. Ther. 2013; 26(2): 157-67.
  32. Taylor A.H., Guzail M., Al-Azzawi F. Differential expression of oestrogen receptor isoforms and androgen receptor in the normal vulva and vagina compared with vulval lichen sclerosus and chronic vaginitis. Br. J. Dermatol. 2008; 158(2): 319-28.
  33. Бурова Е.А. Особенности экскреции половых гормонов и гонадотропинов у девочек, больных склероатрофическим лихеном гениталий. Патогенез и лечение дерматозов у детей. Сборник научных трудов. Горький; 1988: 32-41.
  34. Aide S., Lattario F.R., Almeida G., do Val I.C., da Costa Carvalho M. Epstein-Barr virus and human papillomavirus infection in vulvar lichen sclerosus. J. Low Genit. Tract. Dis. 2010; 14(4): 319-22.
  35. Ашрафян Л.А., Харченко Н.В., Степанова Е.В, Бабаева Н.А. Рак вульвы - этиопатогенетические факторы. Российский онкологический журнал. 2004; 5: 22-5.
  36. Реуцкая М.А., Кулинич С.И. Роль инфекций в генезе заболеваний вульвы. Сибирский медицинский журнал. 2010; 6: 239-42.
  37. Шарапова Л.Е. К вопросу об этиологии и патогенезе хронических дистрофических заболеваний вульвы. Российский вестник акушерства и гинекологии. 2010; 1: 29-34.
  38. Bono W., Dupin N. Localized scleroderma (morphea). Presse Med. 2006; 35(12, Pt. 2): 1923-8.
  39. Дворников А.С. Терапия больных локализованной склеродермией препаратом гиалуронидазы. Вестник дерматологии и венерологии. 2013; 3: 96-100.
  40. Wallace H.J. Lichen sclerosus et atrophicus. Trans. St. Johns Hosp. Dermatol. Soc. 1971; 57(1): 9-30.
  41. Cooper S.M., Gao X.H., Powell J.J., Wojnarowska F. Does treatment of vulvar lichen sclerosus influence its prognosis? Arch. Dermatol. 2004;140(6): 702-6.
  42. Simpkin S., Oakley A. Clinical review of 202 patients with vulval lichen sclerosus: a possible association with psorasis. Australas J. Dermatol. 2007; 48(1): 28-31.
  43. Кряжева С.С., Ромашкина А.С. Поражение наружных половых органов при различных формах ограниченной склеродермии. Актуальные вопросы дерматовенерологии и дерматоонкологии. 2009; 6: 49-50.
  44. Schlosser B.J., Mirowski G.W. Lichen sclerosus and lichen planus in women and girls. Clin. Obstet. Gynecol. 2015; 58(1): 125-42.
  45. Bunker C.B. Genital diseases in men. В кн.: Вольф К., Голдсмит Л.А., Кац С.И., Джилкрест Б.А., Паллер Э.С., Леффель Д.Дж., ред. Дерматология Фицпатрика в клинической практике. Пер. с англ. М.: Изд. Панфилова; БИНОМ. Лаборатория знаний; 2012. т. 2: 731-2.
  46. Aynaud O., Piron D., Casanova J.M. Incidence of preputial lichen sclerosus in adults: histologic study of circumcision specimens. J. Am. Acad. Dermatol. 1999; 41(6): 923-6.
  47. Kantere D., Lowhagen G.B., Alvengren F., Måneskold A., Gillstedt M., Tunback P. The clinical spectrum of lichen sclerosus in male patients-a retrospective study. Acta Derm. Venereol. 2014; 94(5): 542-6.
  48. Fistarol S.K., Itin P.H. Diagnosis and treatment of lichen sclerosus. Am. J. Clin. Dermatol. 2013; 14(1): 27-47.
  49. Pugliese J.M., Morey A.F., Peterson A.C. Lichen sclerosus: review of literature and current recommendations for management. J. Urol. 2007; 178(6): 2268-76.
  50. Wang S.H., Chi C.C., Wong Y.W., Salim A., Manek S., Wojnarowska F. Genital verrucous carcinoma is associated with lichen sclerosus: a retrospective study and review of the literature. J. Eur. Acad. Dermatol. Venereol. 2010; 24(7): 815-9.
  51. Barbagli G., Palminteri E., Mirri F., Guazzoni G., Turini D., Lazzeri M. Penile carcinoma in patients with genital lichen sclerosus: a multicenter survey. J. Urol. 2006; 175(4): 1359-63.
  52. Regauer S. Vulvare und penile karzinogenese: transformierende HPV-high-risk-infektionen und dermatosen (lichen sclerosus und lichen planus). J. Urol. Urogynakol. 2012; 19: 22-5.
  53. Cancer Research UK. UK Vulva Cancer incidence statistics. http://info.cancerresearchuk.org/cancerstats/ (accessed 24th March 2010).
  54. Голдсмит Л.А., Кац С.И., Гилкрест Б.А., Паллер Э.С., Леффелл Д.Дж., Вольф К., ред. Fitzpatrick’s Dermatology in General Medicine. Пер. с англ. 8th ed. М.: Практика-McGraw-Hill; 2015: 286-9.
  55. Юсупова Л.А., Филатова М.А. Локализованная склеродермия: диагностика, клиника, лечение. Лечащий врач. 2014; 5: 51-5.
  56. Vilela F.A., Carneiro S., Ramos-e-Silva M. Treatment of morphea or localized scleroderma: review of the literature. J. Drugs. Dermatol. 2010; 9(10): 1213-9.
  57. Zwischenberger B.A., Jacobe H.T. A systematic review of morphea treatments and therapeutic algorithin. J. Am. Acad. Dermatol. 2011; 65(5): 925-41.
  58. Funaro D., Lovett A., Leroux N., Powell J. A double-blind, randomized prospective study evaluating topical clobetasol propionate 0.05% versus topical tacrolimus 0.1% in patients with vulvar lichen sclerosus. J. Am. Acad. Dermatol. 2014; 71(1): 84-91.
  59. Valdivielso-Ramos M., Bueno C., Hernanz J.M. Significant improvement in extensive lichen sclerosus with tacrolimus ointment and PUVA. Am. J. Clin. Dermatol. 2008; 9(3): 175-9.
  60. Virgili A., Lauriola M.M., Mantovani L., Corazza M. Vulvar lichen sclerosus: 11 women treated with tacrolimus 0.1% ointment. Acta Dermatol. Venereol. 2007; 87(1): 69-72.
  61. Chi C.C., Kirtschig G., Baldo M., Brackenbury F., Lewis F., Wojnarowska F. Topical interventions for genital lichen sclerosus. Cochrane Database Syst. Rev. 2011; (12): CD008240.
  62. Burrows L.J., Creasey A., Goldstein A.T. The treatment of vulvar lichen sclerosus and female sexual dysfunction. J. Sex. Med. 2011; 8(1): 219-22.
  63. Gunthert A.R., Faber M., Knappe G., Hellriegel S., Emons G. Early onset vulvar Lichen Sclerosus in premenopausal women and oral contraceptives. Eur. J. Obstet. Gynecol. Reprod. Biol. 2008; 137(1): 56-60.
  64. Buense R., Duarte I.A., Bouer M. Localized scleroderma: assessment of the therapeutic response to phototherapy. An. Bras. Dermatol. 2012; 87(1): 63-9.

Statistics

Views

Abstract - 42

PDF (Russian) - 0

Cited-By


Article Metrics

Metrics Loading ...

PlumX

Dimensions


Copyright (c) 2019 Semenchak Y.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies